Skip Navigation Links
Forside
VUK, Faglige anbefalinger & præsentationer
Kontakt
Om DSKB
DSKB-Nyt
Møder
Uddannelse
Indmeldelse
Udvalg
Links & tools
  
EFLM consensus paper - Quantifying atherogenic lipoproteins
Company: DSKB
Published by: Malene Bjerregaard Pass
Date: 1/15/2020 11:32:46 AM
Category: General
     

The Chair of the EFLM WG Guidelines, Prof. Michel Langlois, on behalf of the group proudly announces the recent publication of a new EFLM Consensus Paper

“Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM”.

Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM

Clin Chem Lab Med 2019 doi 10.1515/cclm-2019-1253

 

Click here to download the paper

Langlois MR, Nordestgaard BG, Langsted A, Chapman AJ, Aakre KM, Baum H, Borén J, Bruckert E, Catapano A, Cobbaert C, Collinson P, Descamps OS, Duff CJ, von Eckardstein A, Hammerer-Lercher A, Kamstrup PR, Kolovou G, Kronenberg F, Mora S, Pulkki K, Remaley AT, Rifai N, Ros E, Stankovic S, Stavljenic-Rukavina A, Sypniewska G, Watts GF, Wiklund O, LaitinenP, for the European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative



ABOUT THE PAPER

EFLM is proud to announce the recent publication of the Consensus Paper “Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM”.

This document has been produced by EFLM WG-Guidelines and the EFLM Task Group-Cardiac Markers in collaboration with the European Atherosclerosis Society (EAS). This document aims to provide appropriate guidance on the pre-analytical, analytical, and post-analytical phases of laboratory testing of atherogenic lipoproteins.

All EFLM National Societies were invited to take part in the final stage of the development of this document. Public consultation among EFLM National Society Members was held in the first part of 2019. All comments received have been taken into account during the document revision. The revised version has been then sent for final voting to all 40 National Societies and was positively voted by 29 Societies (1 negative vote was received and 10 Societies did not vote) and it can now be considered an official EFLM and EAS statement. We greatly appreciate the comments and suggestions received from EFLM National Societies and their appointed reviewers. 

The Consensus Paper has been recently published in CCLM, the official Journal of EFLM as well as in the EAS journal “Atherosclerosis”.

We encourage professionals throughout Europe to adopt and implement this recommendation!



 

 

Kontakt

Akademisk sekretær
Pernille Just Vinholt
Afdelingslæge, klinisk lektor, ph.d.
Afdeling for Klinisk Biokemi og Farmakologi
Odense Universitetshosptial
E-mail: pernille.vinholt@rsyd.dk

Kontaktformular: Klik her